Track China Botanic Pharmaceutical's common stock ($-54K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (July 2025), CBPI shows a common stock of $-54K. That compares with $19K in the prior-year period — down 385.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CBPI's common stock is now $-54K (was $19K) — a 385.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether China Botanic Pharmaceutical is outperforming or lagging.
Tracking CBPI's common stock over time shows whether China Botanic Pharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $-54K That compares with $19K in the prior-year period — down 385.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has China Botanic Pharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $-54K) with ownership activity and broader fundamentals.